Concepedia

X. Xu

XX

Statistics

Publications

5

Citations

152

H-Index

5

Active since

2012

Affiliations

The Ohio State University(Current)

X. Xu is an author at The Ohio State University specializing in pathology, medicine, and oncology.

ORCID

Top concepts

Publications per year

2012–2018

5

Publications

5

<scp>PBK</scp>/<scp>TOPK</scp> expression in non‐small‐cell lung cancer: its correlation and prognostic significance with <scp>K</scp>i67 and p53 expression

Bin Lei, Shuguang Liu, Wenjuan Qi et al. · Histopathology · 2013 · 70 citations

UPP mediated Diabetic Retinopathy via ROS/PARP and NF-κB inflammatory factor pathways.

Dawei Luo, Zong‐Ping Zheng, Hao-Yuan Wang et al. · Current Molecular Medicine · 2015 · 30 citations

, , +14

P1.01-81 Phase 3 Study of Pemetrexed-Platinum with or without Pembrolizumab for TKI-Resistant/EGFR-Mutated Advanced NSCLC: KEYNOTE-789

Greg J. Riely, Rina Hui, David P. Carbone et al. · Journal of Thoracic Oncology · 2018 · 23 citations

, , +8

The clinicopathological significance of REIC expression in colorectal carcinomas.

Wei Wang, Wan Zhu, X. Xu et al. · PubMed · 2012 · 15 citations

, , +10

A patient with classic biphasic pulmonary blastoma harboring&lt;em&gt; CD74&amp;ndash;ROS1&lt;/em&gt; fusion responds to crizotinib

Zhaoting Meng, Peng Chen, Fenglin Zang et al. · OncoTargets and Therapy · 2017 · 14 citations · Full text

, , +16

Rows per page

1–5 of 5